Effects of denosumab on peripheral lymphocyte subpopulations

Endocrine. 2016 Sep;53(3):857-9. doi: 10.1007/s12020-015-0723-6. Epub 2015 Aug 20.
No abstract available

MeSH terms

  • Aged
  • Aged, 80 and over
  • Bone Density Conservation Agents / pharmacology*
  • Bone Density Conservation Agents / therapeutic use
  • Denosumab / pharmacology*
  • Denosumab / therapeutic use
  • Female
  • Humans
  • Lymphocyte Subsets / drug effects*
  • Middle Aged
  • Osteoporosis, Postmenopausal / drug therapy*
  • Treatment Outcome

Substances

  • Bone Density Conservation Agents
  • Denosumab